# Clearone Inc: financial statements, quarterly

CLRO · Nasdaq · CIK 840715 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/clro.md) · [Financials](/companies/clro/financials.md) · [Filings](/companies/clro/filings.md) · [Insiders](/companies/clro/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/clro/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4.9](/filings/0001753926-24-001912.md) | [4.2 d](/filings/0001753926-25-000516.md) | [3.6](/filings/0001753926-25-000847.md) | [2.3](/filings/0001753926-25-001345.md) | [0.0](/filings/0001753926-25-001796.md) | [0.0 d](/filings/0001753926-26-000600.md) | [0.0](/filings/0001753926-26-000897.md) | [0.0](/filings/0001753926-26-001521.md) | [0.0](/filings/0001753926-25-001796.md) | [0.0 d](/filings/0001753926-26-000600.md) | [0.0](/filings/0001753926-26-000897.md) | [0.0](/filings/0001753926-26-001521.md) |
| Cost of revenue | $m | [3.3](/filings/0001753926-24-001912.md) | [2.6 d](/filings/0001753926-25-000516.md) | [2.5](/filings/0001753926-25-000847.md) | [2.3](/filings/0001753926-25-001345.md) | [0.0](/filings/0001753926-25-001796.md) | [0.1 d](/filings/0001753926-26-000600.md) | [0.0](/filings/0001753926-26-000897.md) | [0.1](/filings/0001753926-26-001521.md) | [0.0](/filings/0001753926-25-001796.md) | [0.2 d](/filings/0001753926-26-000600.md) | [0.1](/filings/0001753926-26-000897.md) | [0.1](/filings/0001753926-26-001521.md) |
| Gross profit | $m | [1.6](/filings/0001753926-24-001912.md) | [1.6 d](/filings/0001753926-25-000516.md) | [1.2](/filings/0001753926-25-000847.md) | [(0.0)](/filings/0001753926-25-001345.md) | [(0.0)](/filings/0001753926-25-001796.md) | [(0.1) d](/filings/0001753926-26-000600.md) | [(0.0)](/filings/0001753926-26-000897.md) | [(0.1)](/filings/0001753926-26-001521.md) | [(0.0)](/filings/0001753926-25-001796.md) | [(0.2) d](/filings/0001753926-26-000600.md) | [(0.1)](/filings/0001753926-26-000897.md) | [(0.1)](/filings/0001753926-26-001521.md) |
| Research and development | $m | [0.9](/filings/0001753926-24-001912.md) | [0.9 d](/filings/0001753926-25-000516.md) | [0.9](/filings/0001753926-25-000847.md) | [0.9](/filings/0001753926-25-001345.md) | [0.0](/filings/0001753926-25-001796.md) | [3.3 d](/filings/0001753926-25-000516.md) | [0.0](/filings/0001753926-26-000897.md) | [0.0](/filings/0001753926-26-001521.md) | [0.0](/filings/0001753926-25-001796.md) | not reported | [0.0](/filings/0001753926-26-000897.md) | [0.0](/filings/0001753926-26-001521.md) |
| Operating income | $m | [(1.5)](/filings/0001753926-24-001912.md) | [(1.7) d](/filings/0001753926-25-000516.md) | [(2.1)](/filings/0001753926-25-000847.md) | [(2.9)](/filings/0001753926-25-001345.md) | [(0.8)](/filings/0001753926-25-001796.md) | [0.4 d](/filings/0001753926-26-000600.md) | [(0.8)](/filings/0001753926-26-000897.md) | [(1.2)](/filings/0001753926-26-001521.md) | [(0.9)](/filings/0001753926-25-001796.md) | [(1.1) d](/filings/0001753926-26-000600.md) | [(0.9)](/filings/0001753926-26-000897.md) | [(0.9)](/filings/0001753926-26-001521.md) |
| Interest expense | $m | [0.1](/filings/0001753926-24-001912.md) | [0.1 d](/filings/0001753926-24-000656.md) | [0.0](/filings/0001753926-25-000847.md) | [0.0](/filings/0001753926-25-001345.md) | [(0.0)](/filings/0001753926-25-001796.md) | not reported | [0.0](/filings/0001753926-26-000897.md) | [0.0](/filings/0001753926-26-001521.md) | [0.0](/filings/0001753926-25-001796.md) | not reported | [0.0](/filings/0001753926-26-000897.md) | [0.0](/filings/0001753926-26-001521.md) |
| Income tax | $m | [0.0](/filings/0001753926-24-001912.md) | [0.4 d](/filings/0001753926-25-000516.md) | [(0.0)](/filings/0001753926-25-000847.md) | [0.0](/filings/0001753926-25-001345.md) | [0.0](/filings/0001753926-25-001796.md) | [0.1 d](/filings/0001753926-26-000600.md) | [0.0](/filings/0001753926-26-000897.md) | [0.0](/filings/0001753926-26-001521.md) | [0.0](/filings/0001753926-25-001796.md) | [0.1 d](/filings/0001753926-26-000600.md) | [0.0](/filings/0001753926-26-000897.md) | [0.0](/filings/0001753926-26-001521.md) |
| Net income | $m | [(1.4)](/filings/0001753926-24-001912.md) | [2.6 d](/filings/0001753926-25-000516.md) | [(1.9)](/filings/0001753926-25-000847.md) | [(2.8)](/filings/0001753926-25-001345.md) | [(2.1)](/filings/0001753926-25-001796.md) | [(2.2) d](/filings/0001753926-26-000600.md) | [(2.8)](/filings/0001753926-26-000897.md) | [(4.6)](/filings/0001753926-26-001521.md) | [(13.7)](/filings/0001753926-25-001796.md) | [(4.9) d](/filings/0001753926-26-000600.md) | [(0.5)](/filings/0001753926-26-000897.md) | [(0.9)](/filings/0001753926-26-001521.md) |
| Diluted EPS | $ per share | [(0.06)](/filings/0001753926-24-001912.md) | not reported | [(0.08)](/filings/0001753926-25-000847.md) | [(1.76)](/filings/0001753926-25-001345.md) | [(1.29)](/filings/0001753926-25-001796.md) | not reported | [(1.71)](/filings/0001753926-26-000897.md) | [(2.64)](/filings/0001753926-26-001521.md) | [(7.92)](/filings/0001753926-25-001796.md) | not reported | [(0.18)](/filings/0001753926-26-000897.md) | [(0.34)](/filings/0001753926-26-001521.md) |
| Basic EPS | $ per share | [(0.06)](/filings/0001753926-24-001912.md) | not reported | [(0.08)](/filings/0001753926-25-000847.md) | [(1.76)](/filings/0001753926-25-001345.md) | [(1.29)](/filings/0001753926-25-001796.md) | not reported | [(1.71)](/filings/0001753926-26-000897.md) | [(2.64)](/filings/0001753926-26-001521.md) | [(7.92)](/filings/0001753926-25-001796.md) | not reported | [(0.21)](/filings/0001753926-26-000897.md) | [(0.34)](/filings/0001753926-26-001521.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [13.7](/filings/0001753926-23-001453.md) | [17.8](/filings/0001753926-25-000516.md) | [18.5](/filings/0001753926-24-000998.md) | [2.5](/filings/0001753926-24-001441.md) | [1.7](/filings/0001753926-24-001912.md) | [1.4](/filings/0001753926-26-000600.md) | [1.0](/filings/0001753926-25-000847.md) | [1.1](/filings/0001753926-25-001345.md) | [0.1](/filings/0001753926-25-001796.md) | [0.2](/filings/0001753926-26-001521.md) | [0.8](/filings/0001753926-26-000897.md) | [0.1](/filings/0001753926-26-001521.md) |
| Current assets | $m | [42.1](/filings/0001753926-23-001453.md) | [43.3](/filings/0001753926-25-000516.md) | [39.6](/filings/0001753926-24-000998.md) | [25.4](/filings/0001753926-24-001441.md) | [23.0](/filings/0001753926-24-001912.md) | [18.8](/filings/0001753926-26-000600.md) | [17.1](/filings/0001753926-25-000847.md) | [16.9](/filings/0001753926-25-001345.md) | [8.6](/filings/0001753926-25-001796.md) | [1.7](/filings/0001753926-26-001521.md) | [1.7](/filings/0001753926-26-000897.md) | [1.0](/filings/0001753926-26-001521.md) |
| Total assets | $m | [49.1](/filings/0001753926-23-001453.md) | [50.7](/filings/0001753926-25-000516.md) | [48.2](/filings/0001753926-24-000998.md) | [30.8](/filings/0001753926-24-001441.md) | [28.4](/filings/0001753926-24-001912.md) | [26.5](/filings/0001753926-26-000600.md) | [24.7](/filings/0001753926-25-000847.md) | [24.0](/filings/0001753926-25-001345.md) | [9.5](/filings/0001753926-25-001796.md) | [2.3](/filings/0001753926-26-001521.md) | [2.0](/filings/0001753926-26-000897.md) | [1.0](/filings/0001753926-26-001521.md) |
| Current liabilities | $m | [5.3](/filings/0001753926-23-001453.md) | [4.3](/filings/0001753926-25-000516.md) | [18.2](/filings/0001753926-24-000998.md) | [3.7](/filings/0001753926-24-001441.md) | [3.3](/filings/0001753926-24-001912.md) | [3.5](/filings/0001753926-26-000600.md) | [3.6](/filings/0001753926-25-000847.md) | [7.5](/filings/0001753926-25-001345.md) | [3.8](/filings/0001753926-25-001796.md) | [1.5](/filings/0001753926-26-001521.md) | [0.9](/filings/0001753926-26-000897.md) | [0.9](/filings/0001753926-26-001521.md) |
| Total liabilities | $m | [7.1](/filings/0001753926-23-001453.md) | [6.0](/filings/0001753926-25-000516.md) | [19.9](/filings/0001753926-24-000998.md) | [5.2](/filings/0001753926-24-001441.md) | [4.9](/filings/0001753926-24-001912.md) | [5.2](/filings/0001753926-26-000600.md) | [5.2](/filings/0001753926-25-000847.md) | [9.1](/filings/0001753926-25-001345.md) | [5.3](/filings/0001753926-25-001796.md) | [3.0](/filings/0001753926-26-001521.md) | [1.5](/filings/0001753926-26-000897.md) | [1.4](/filings/0001753926-26-001521.md) |
| Long-term debt | $m | not reported | [0.0](/filings/0001753926-24-000656.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [1.2](/filings/0001753926-23-001453.md) | [0.0](/filings/0001753926-24-000656.md) | not reported | not reported | not reported | [0.0](/filings/0001753926-25-001345.md) | not reported | [3.0](/filings/0001753926-25-001345.md) | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [42.0](/filings/0001753926-24-001912.md) | [44.7](/filings/0001753926-25-000516.md) | [28.3](/filings/0001753926-25-000847.md) | [25.6](/filings/0001753926-25-001345.md) | [23.5](/filings/0001753926-25-001796.md) | [21.3](/filings/0001753926-26-000600.md) | [19.5](/filings/0001753926-26-000897.md) | [14.9](/filings/0001753926-26-001521.md) | [3.5](/filings/0001753926-25-001796.md) | [(0.7)](/filings/0001753926-26-001521.md) | [0.5](/filings/0001753926-26-000897.md) | [(0.4)](/filings/0001753926-26-001521.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.8) d](/filings/0001753926-24-001912.md) | [3.5 d](/filings/0001753926-25-000516.md) | [0.4](/filings/0001753926-25-000847.md) | [(3.2) d](/filings/0001753926-25-001345.md) | [(1.9) d](/filings/0001753926-24-001912.md) | [(1.5) d](/filings/0001753926-25-000516.md) | [(1.4)](/filings/0001753926-25-000847.md) | [(1.1) d](/filings/0001753926-25-001345.md) | [(0.8) d](/filings/0001753926-25-001796.md) | [(11.2) d](/filings/0001753926-26-000600.md) | [(0.7)](/filings/0001753926-26-000897.md) | [(0.9) d](/filings/0001753926-26-001521.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001753926-24-001912.md) | [0.0 d](/filings/0001753926-25-000516.md) | [0.1](/filings/0001753926-25-000847.md) | [0.1 d](/filings/0001753926-25-001345.md) | [0.0 d](/filings/0001753926-25-001796.md) | [0.0 d](/filings/0001753926-25-000516.md) | [0.0](/filings/0001753926-25-000847.md) | [0.0 d](/filings/0001753926-25-001345.md) | [0.0 d](/filings/0001753926-25-001796.md) | not reported | not reported | not reported |
| Dividends paid | $m | [0.0 d](/filings/0001753926-24-001912.md) | [0.0 d](/filings/0001753926-25-000516.md) | not reported | not reported | [0.0 d](/filings/0001753926-25-001796.md) | [0.0 d](/filings/0001753926-26-000600.md) | not reported | not reported | [0.0 d](/filings/0001753926-25-001796.md) | [0.0 d](/filings/0001753926-26-000600.md) | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.0](/filings/0001753926-23-001453.md) | [24.0](/filings/0001753926-24-000998.md) | [24.0](/filings/0001753926-24-001441.md) | [24.0](/filings/0001753926-24-001912.md) | [24.0](/filings/0001753926-25-000847.md) | [1.6](/filings/0001753926-25-001345.md) | [1.6](/filings/0001753926-25-001796.md) | [1.6](/filings/0001753926-26-000897.md) | [1.7](/filings/0001753926-26-001521.md) | [1.7](/filings/0001753926-25-001796.md) | [2.8](/filings/0001753926-26-000897.md) | [2.7](/filings/0001753926-26-001521.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,675,412 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001753926-26-001521.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.